STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
LAB on Nasdaq
Shares outstanding
384,731,503
Price per share
$1.28
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
285,864,576
Total reported value
$371,613,646
% of total 13F portfolios
0%
Share change
+5,131,635
Value change
+$7,179,113
Number of holders
155
Price from insider filings
$1.28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Casdin Capital, LLC 24% +12% $107,459,205 +$14,465,243 93,442,787 +16% Eli Casdin 25 Nov 2025
MAK Capital Fund LP 5.2% $25,564,473 19,967,565 MAK Capital Fund LP 31 Dec 2025

As of 30 Sep 2025, 155 institutional investors reported holding 285,864,576 shares of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB). This represents 74% of the company’s total 384,731,503 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Casdin Capital, LLC 20% 77,558,856 +1.9% 8.4% $100,826,513
VIKING GLOBAL INVESTORS LP 15% 58,651,170 0% 0.2% $76,246,521
BlackRock, Inc. 6.5% 24,920,918 +0.39% 0% $32,397,194
VANGUARD GROUP INC 4.5% 17,245,583 +1.6% 0% $22,419,257
MAK CAPITAL ONE LLC 4.1% 15,931,806 +185% 4.1% $20,711,348
Long Focus Capital Management, LLC 3% 11,362,804 +13% 0.87% $14,771,645
GEODE CAPITAL MANAGEMENT, LLC 1.9% 7,468,917 +0.37% 0% $9,711,117
STATE STREET CORP 1.7% 6,402,649 +1.6% 0% $8,323,444
MORGAN STANLEY 1.7% 6,355,152 +2.1% 0% $8,261,698
Hollow Brook Wealth Management LLC 1.5% 5,775,739 +2.9% 1.8% $7,508,461
Sumitomo Mitsui Trust Group, Inc. 1.4% 5,391,829 -13% 0% $7,009,378
Amova Asset Management Americas, Inc. 1.4% 5,391,829 -12% 0.07% $7,009,378
NEUBERGER BERMAN GROUP LLC 1.2% 4,725,812 +4.7% 0% $6,136,032
Tikvah Management LLC 0.92% 3,551,152 -30% 1.4% $4,616,498
BARCLAYS PLC 0.83% 3,174,634 -4% 0% $4,127,025
ARK Investment Management LLC 0.79% 3,021,728 -4.2% 0.02% $3,928,246
ROYCE & ASSOCIATES LP 0.73% 2,804,719 +6.4% 0.04% $3,646,135
NORTHERN TRUST CORP 0.67% 2,593,910 -2.5% 0% $3,372,083
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.65% 2,504,180 -1.5% 0% $3,255,434
Nan Fung Group Holdings Ltd 0.49% 1,883,179 0% 4.1% $2,448,133
Slate Path Capital LP 0.42% 1,615,000 0% 0.03% $2,099,500
MILLENNIUM MANAGEMENT LLC 0.38% 1,453,575 -38% 0% $1,889,647
Pacific Capital Partners Ltd 0.34% 1,325,000 -3.6% 1.9% $1,722,500
GOLDMAN SACHS GROUP INC 0.34% 1,295,966 -1.8% 0% $1,684,756
Bank of New York Mellon Corp 0.21% 798,138 +2.6% 0% $1,037,580

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 614,139 $785,441 -$1,033,473 $1.28 11
2025 Q3 285,864,576 $371,613,646 +$7,179,113 $1.30 155
2025 Q2 280,617,967 $336,678,756 -$1,077,642 $1.20 160
2025 Q1 281,593,693 $304,150,084 +$2,261,566 $1.08 146
2024 Q4 278,358,368 $487,065,327 -$5,657,176 $1.75 142
2024 Q3 280,366,207 $541,005,737 +$18,823,597 $1.93 140
2024 Q2 270,524,655 $478,727,355 -$3,832,782 $1.77 141
2024 Q1 265,331,247 $719,038,567 +$581,984,034 $2.71 145
2023 Q4 4,452,808 $9,872,557 +$84,046 $2.21 3
2023 Q3 880 $1,848 -$412,228 $2.10 1
2023 Q2 46,157,930 $89,085,103 +$15,267 $1.93 65
2023 Q1 46,097,170 $89,907,739 -$84,817 $1.95 68
2022 Q4 46,480,180 $54,401,276 -$779,635 $1.17 63
2022 Q3 38,636,548 $42,509,290 -$7,841,930 $1.10 59
2022 Q2 43,675,190 $69,879,656 -$16,196,064 $1.60 75
2022 Q1 49,092,800 $176,403,697 -$25,051,894 $3.59 100
2021 Q4 55,510,754 $217,368,393 -$15,389,024 $3.92 115
2021 Q3 58,557,480 $386,054,880 +$7,304,084 $6.59 114
2021 Q2 57,570,756 $354,363,486 +$243,871 $6.16 110
2021 Q1 58,699,962 $265,689,403 -$42,325,026 $4.52 132
2020 Q4 65,288,038 $391,634,950 -$13,617,286 $6.00 141
2020 Q3 65,395,220 $486,139,526 +$35,830,119 $7.43 129
2020 Q2 62,199,691 $249,441,661 -$3,145,595 $4.01 109
2020 Q1 59,665,966 $151,528,520 -$1,036,652 $2.54 97
2019 Q4 63,091,597 $219,541,158 -$9,645,262 $3.48 96
2019 Q3 63,851,630 $295,718,385 -$62,716,223 $4.63 122
2019 Q2 69,810,820 $860,021,233 +$95,072,380 $12.32 131
2019 Q1 64,260,954 $853,996,750 +$79,413,578 $13.29 130
2018 Q4 49,428,619 $426,070,543 +$92,703,369 $8.62 98
2018 Q3 38,823,079 $290,789,367 +$6,187,732 $7.49 76
2018 Q2 38,051,469 $226,778,750 +$7,205,236 $5.96 83
2018 Q1 37,017,522 $216,208,343 +$1,751,502 $5.84 82
2017 Q4 36,719,372 $217,359,750 +$4,379,642 $5.89 80
2017 Q3 36,202,166 $182,458,122 +$50,183,902 $5.04 76
2017 Q2 26,171,325 $105,722,221 -$4,726,880 $4.04 74
2017 Q1 27,134,271 $154,386,592 +$9,951,019 $5.69 77
2016 Q4 26,892,856 $195,601,510 -$9,618,902 $7.28 79
2016 Q3 27,178,593 $217,635,922 -$2,987,637 $8.01 89
2016 Q2 27,257,808 $246,136,890 -$13,983,552 $9.03 92
2016 Q1 28,524,368 $230,262,557 -$7,002,368 $8.07 92
2015 Q4 28,331,449 $306,249,733 -$18,657,396 $10.81 101
2015 Q3 30,880,705 $250,427,548 -$43,612,470 $8.11 99
2015 Q2 30,632,385 $741,002,524 -$48,246,196 $24.20 103
2015 Q1 27,968,893 $1,176,177,148 +$27,600,794 $42.10 102
2014 Q4 27,424,314 $924,968,502 +$53,405,274 $33.73 98
2014 Q3 28,599,338 $700,679,693 +$41,851,163 $24.50 97
2014 Q2 26,684,722 $784,490,600 -$1,610,368 $29.40 104
2014 Q1 25,832,862 $1,137,171,282 +$79,373,686 $44.07 104